Infinity Pharmaceuticals initiated with a Buy at B. Riley FBR. B. Riley FBR George Zavoico started Infinity Pharmaceuticals with a Buy rating and $3 price target. The company could “hold the key” to improving checkpoint inhibitors in cancer, Zavoico tells investors in a research note.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.